期刊文献+

细胞凋亡在慢性髓性白血病加速、急变期中的意义 被引量:3

Significance of Apoptosis during the Progression of Chronic Myeloid Leukemia
下载PDF
导出
摘要 目的:探讨细胞凋亡在慢性髓性白血病(chronicmyeloidleukemia,CML)加速、急变中的意义。方法:CML不同临床分期的41例患者,分离骨髓单个核细胞(bonemarrowmononeuclearcells,BMMNC),用DNA凝胶电泳、流式细胞仪及原位末端标记法检测细胞凋亡,荧光分光光度法检测caspase3活性,流式细胞仪测定细胞周期分布。结果:CML各组用DNA凝胶电泳法均未见梯状条带;流式细胞仪及原位末端标记法检测细胞凋亡,发现CML各组间未见显著差异;急变期组caspase3活性明显低于慢性期未治疗组及治疗组;急变期组较慢性期组G0/G1期细胞显著增多,S期细胞显著减少。随访19例慢性加速期组患者,发现5例1年内发生急变,未急变者与急变者caspase3活性分别为86.91±23.42及69.85±15.37,P>0.05。结论:细胞凋亡受抑可能在CML急变形成过程中发挥一定的作用。 Objective:To explore the significance of apoptosis during the progression of chronic myeloid leukemia(CML).Methods:BMMNC were separated from41CML patients of dif-ferent clinical phases.Apoptosis was detected by DNA gel electrophoresis,cytometry and in situ end labeling.Caspase3activity and cell cycle were detected by fluorometry and flow cytom etry respectively.Results:No DNA ladder was found in BMMNC of all the patients.No siog nifi cant difference of apoptosis was found between the BMMNC from patients of different clinical phasesby either cytometry or in situ end labeling.The caspase3activity was decreasedduring the progres-sion of CML.Compared with CP patients,the cell cycles of BMMNC of BC ones were character-ized by significantly higher G0/G1and lower S cell fraction.Follow-up was carried out in15CP and4AP patients for one year,BC was taken place in2CP and3AP ones.The caspase3ac-tivity of patients undergoing BC versus no BC were69.85±15.37vs86.91±23.42(P>0.05).Con-clu sion:The inhibition of apoptosis may play a role in the blastic transition of CML.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2002年第2期91-94,共4页 Chinese Journal of Clinical Oncology
基金 山东省卫生厅科研基金资助(1997CA1CJB3)
关键词 髓细胞性白血病 急变期 细胞凋亡 CASPASE3 Leukemia Myeloid Chronic Apoptosis Blastic crisis caspase3
  • 相关文献

参考文献1

  • 1陆道培.白血病治疗学[M].北京:科技出版社,1994.302.

共引文献30

同被引文献37

  • 1Dowdy SC, O′ Kane DJ, Keeney GL, et al. Telomerase activity in sex cord- stromal tumors of the ovary [J]. Gynecol Oncol, 2001, 82(2): 257-260.
  • 2Poremba C, Heine B, Diallo R, et al. Telomerase as a prognostic marker in breast cancer: high - throughput tissue microarray analysis of hTERT and hTR [J]. J Pathol, 2002, 198(2): 181 - 189.
  • 3Shiratsuchi M, Muta K, Abe Y, et al. Clinical significance of telomerase activity in multiple myeloma [J]. Cancer, 2002, 94(8): 2232- 2238.
  • 4OishiT, KigawaJ, MinagawaY, etal. Alteration oftelomerase activity associated with development and extension of epithelial ovarian cancer [J]. Obstet Gynecol, 1998, 91(4): 568-571.
  • 5Shahin MS, Hughos JH, Sood AK, et al. The prognostic significance of po53 tumor suppreessor gene alterations in ovarian carcinoma [ J ].Cancer, 2000, 89(9): 2006-2017.
  • 6Eltabbakh GH, Belinson JL, Kennedy AW, et al. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer [J]. Cancer, 1997, 80(5): 892 - 898.
  • 7Kobayashi T, Sugawara Y, Shi YZ, et al. Telomerase expression and p53 status in hepatocellular carcinoma [ J ]. Am J Gastroenterol,2002, 97(12): 3166-3171.
  • 8Karlseder J, Broccoli D, Dai Y, et al. p53 - and ATM - dependent apoptosis induced by telomeres lacking TRF2 [J]. Science, 1999,283(5406): 1321 - 1325.
  • 9Vaziri H, Benchimol S. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase[J]. Oncogene, 1999, 18(53): 7676-7680.
  • 10Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide - ranging implication in tissue kinetics [J]. Br J Cancer, 1972, 26(4): 239 - 257.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部